1. Adelaide Research & Scholarship

Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.001 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2014The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the la-specific antibody APOMAB®Staudacher, A.; Al-ejeh, F.; Fraser, C.; Darby, J.; Roder, D.; Ruszkiewicz, A.; Manavis, J.; Brown, M.
2015BRAF and MEK inhibition variably affect GD2-specific chimeric antigen receptor (CAR) T-cell function in vitroGargett, T.; Fraser, C.; Dotti, G.; Yvon, E.; Brown, M.
2013An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvantStevens, N.; Fraser, C.; Alsharifi, M.; Brown, M.; Diener, K.; Hayball, J.; Ferro, V.A.
2009Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivoFraser, C.; Blake, S.; Diener, K.; Lyons, A.; Brown, M.; Hughes, T.; Hayball, J.
2010Induction of both cellular and humoral immunity following a rational prime-boost immunization regimen that incorporates recombinant ovine atadenovirus and fowlpox virusFraser, C.; Diener, K.; Lousberg, E.; Both, G.; Ward, L.; Brown, M.; Hayball, J.
2007Improving vaccines by incorporating immunological coadjuvantsFraser, C.; Diener, K.; Brown, M.; Hayball, J.
2010Unravelling the complexity of cancer-immune system interplayFraser, C.; Brown, M.; Diener, K.; Hayball, J.
2010Dasatinib alters the metastatic phenotype of B16-OVA melanoma in vivoFraser, C.; Lousberg, E.; Guerin, L.; Hughes, T.; Brown, M.; Diener, K.; Hayball, J.

Discover